Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Cellebrite DI (CLBT) Invested Capital (2020 - 2025)

Historic Invested Capital for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $484.3 million.

  • Cellebrite DI's Invested Capital rose 4413.37% to $484.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $484.3 million, marking a year-over-year increase of 4413.37%. This contributed to the annual value of $484.3 million for FY2025, which is 4413.37% up from last year.
  • Latest data reveals that Cellebrite DI reported Invested Capital of $484.3 million as of Q4 2025, which was up 4413.37% from $336.0 million recorded in Q4 2024.
  • Cellebrite DI's Invested Capital's 5-year high stood at $484.3 million during Q4 2025, with a 5-year trough of -$130.0 million in Q3 2021.
  • For the 5-year period, Cellebrite DI's Invested Capital averaged around $88.5 million, with its median value being $34.2 million (2023).
  • As far as peak fluctuations go, Cellebrite DI's Invested Capital plummeted by 21495.67% in 2021, and later soared by 88217.0% in 2024.
  • Over the past 5 years, Cellebrite DI's Invested Capital (Quarter) stood at -$73.3 million in 2021, then soared by 200.71% to $73.9 million in 2022, then tumbled by 53.68% to $34.2 million in 2023, then skyrocketed by 882.17% to $336.0 million in 2024, then skyrocketed by 44.13% to $484.3 million in 2025.
  • Its Invested Capital stands at $484.3 million for Q4 2025, versus $336.0 million for Q4 2024 and $34.2 million for Q4 2023.